• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
ASCPT Podcast Channel
MENU  
  • Home
  • About
  • Episodes
  • PSPod
  • ClinPharmPod

Tagged: rare diseases

What’s New in Neuroscience?

March 19, 2022

Clinical Pharmacology & Therapeutics recently published its second themed issue of 2022 – Therapeutics in Neuroscience. Join Editor-in-Chief Dr. Piet van der Graaf and Associate/Guest Editors Drs. Spiros Vamvakas, Paulien Ravenstijn, and Iris Minichmayr as they delve into reasons for the theme, what papers caught their eyes, and what action items they hope to leave with readers. If you’re interested in submitting your research for any upcoming themed issues in ASCPT’s Journal Family, you can find Calls for Papers and more information here.

ClinPharmPod
ClinPharmPod
What’s New in Neuroscience?
Loading
00:00 / 13:07
RSS Feed
Share
Link
Embed

Download file | Play in new window | Duration: 13:07 | Recorded on March 18, 2022

Tagged With: Alzheimer's Disease, Amyotrophic Lateral Sclerosis, ASCPT, Biomarkers, Clinical Pharmacology and Therapeutics, ClinPharmPod, CPT, Food and Drug Administration, Gene Therapy, Huntington's Disease, Neuroscience, rare diseasesChannel: ClinPharmPod

Marlene Haffner on Orphan Drugs

November 28, 2016

This episode features Marlene Haffner, MD, MPH of Haffner Associates, LLC discussing orphan drug regulation in the United States and beyond. Read her article which published in the October 2016 issue here.

Listen and subscribe for free on iTunes and Google Play

ClinPharmPod
ClinPharmPod
Marlene Haffner on Orphan Drugs
Loading
00:00 / 19:50
RSS Feed
Share
Link
Embed

Download file | Play in new window | Duration: 19:50

Tagged With: ASCPT, Clinical Pharmacology and Therapeutics, Orphan drugs, rare diseases, small patient populationsChannel: ClinPharmPod

  • « Go to Previous Page
  • Page 1
  • Page 2

Primary Sidebar

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2020-2026 John Wiley & Sons, Inc. All Rights Reserved.
Wiley